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ABSTRACT 
 
Toward Neuroactive Pyrrolidines and Synthetic Efficiency: Development of 
an Asymmetric Aza-Michael Aldol-Lactonization Organocascade Process. (May 2013) 
  
 
Bianca Lizette Ramirez 
Department of Chemistry 
Texas A&M University 
 
 
Research Advisor: Dr. Daniel Romo 
Department of Chemistry 
 
 
Described is the development an asymmetric aza-Michael aldol-lactonization organocascade 
process. This process enables the synthesis of highly-substituted pyrrolidines from α-amino 
ketones through an organocascade process. Boc-N-(L)-phenylalanine and Ts-N-(L)-alanine α-
amino ketone substrates were synthesized by carrying out Weinreb ketone syntheses on their 
parent α-amino acid. The α-amino ketone substrates and acryloyl chloride were subjected to 
different aza-Michael aldol-lactonization conditions in order to test for the efficiency at which 
they react to form pyrrolidine products. The Ts-N-(L)-alanine α-amino ketone substrate, when 
reacted with homobenzootetramisole (  HBTM) as a nucleophile promoter and EtN(i-Pr)2 as 
stoichiometric base, showed the most promise in favoring the formation of pyrrolidine products.   
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NOMENCLATURE 
 
Bn   benzyl  
 
Boc   tert-butyloxycarbonyl 
 
CDCl3   chloroform-d 
 
CH2Cl2  dichloromethane 
 
DCC   N,N'-dicyclohexylcarbodiimide 
 
DMAP   4-dimethylaminopyridine 
 
EtN(i-Pr)2  N,N-diisopropylethylamine 
 
EDCI   1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
 
EtOAc   ethyl acetate 
 
h    hour 
 
IR   infrared spectroscopy  
 
HOBt   hydroxybenzotriazole 
 
HBTM   homobenzotetramisol 
 
LiHMDS  lithium bis(trimethylsilylamide) 
 
Me   methyl  
 
CD3OD  methanol-d4 
 
NMM   N-methylmorpholine 
 
PMB   para-methoxybenzyl  
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PMP   para-methoxyphenyl 
 
R   alkyl group 
 
THF   tetrahydrofuran 
 
Ts   tosyl 
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CHAPTER I 
 
AN INTRODUCTION TO PYRROLIDINES AND THE PRECEDENT 
BEHIND THE DEVELOPMENT OF THE ASYMMETRIC AZA-MICHAEL 
ALDOL-LACTONIZATION ORGANOCASCADE PROCESS 
 
 
Introduction 
Pyrrolidines are the subject of coninued studies in organic synthesis, with a primary focus the 
simplification of their construction.
1
 Pyrrolidines are targeted by synthetic methodology studies 
and are commonly found in natural product synthesis.
2
 Pyrrolidines are an important structural 
component in many chiral catalysts for imine and enamine based organocatalytic reactions.
3
 
Pyrrolidines also plays a pertinent role in biological chemistry due to their recurrence in 
numerous bioactive natural products such as spirotryprostatin B, which has shown to inhibit 
progression in the cell cycle from the G2 phase to the M phase, and brouaonetinines, which are 
strong inhibitors of α- and β-glucosidase and other enzymes which are involved in the 
breakdown of carbohydrates.
4,5 
The pyrrolidine ring structure is also present in an important class 
of naturally occurring organic compounds called alkaloids. Alkaloids, which contain at least one 
nitrogen atom in a heterocyclic ring, have been discovered to possess many neuroactive 
properties and are known to interact with receptors at nerve endings.
6
 Because of the potent 
neuroactive properties of nitrogen containing heterocycles, the pyrrolidine moiety is an important 
structural motif that appears in the structures of anticonvulsant active molecules which are 
currently being used in pharmaceutical drugs such as Keppra to treat epilepsy.
7,8  
In addition, 
pyrrolidine-based compounds, such as saxagliptin, are currently being sold as a hypoglycemic 
9 
 
drugs used in the treatment of diabetes due to their inhibitory properties toward dipeptidyl 
peptidase-4 (DPP-4).
9
 
 
 
 
 
 
 
 
 
 
 
 
Literature precedent 
The recently developed Nucleophile-Catalyzed Michael Aldol- Lactonization (NCMAL) enables 
construction of cis-fused β-lactones with a 4, 5 ring system through an organocascade process.10 
In the NCMAL, a Lewis base or nucleophile is used to activate an acid chloride in order to 
produce an α, β-unsaturated acyl ammonium species. A base, LiHMDS, is used to form an 
enolate by α-deprotection. The nucleophilic enolate attacks the acyl ammonium species by 1, 4 
Michael addition to produce an ammonium enolate. This enolate in turn undergoes an 
intermolecular aldol-lactonization to yield a cis 4, 5 ring β-lactone. 
 
 
Figure 1. The structure of pyrrolidine along with the structure of several pyrrolidine based 
alkaloids and pharmaceutical agents. 
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 Further precedent for this project comes from the Corey involving a failed acylation attempt of 
acryloyl chloride 1 with amino ketone 2 shown in Scheme 1.
11 
Surprisingly, the  
 
 
 
 
reaction favored a 1,4 Michael addition of 2 to 1 followed by an internal cyclization which 
yielded 3a, a highly substituted pyrrolidine with an attached β-lactone, as the major product. 3b, 
the product of N-acylation, and 3c, the diastereomer of 3a were isolated as minor products. This 
unexpected formation of 3a and 3b could also be controlled by varying the conditions under 
which the reaction was carried out. The ratio of acylation addition to pyrrolidine formation 
varied with the use of different catalytic amines. Corey’s group found that hindered bases such as 
2,6-di-tert-butylpyridine and triisobutylamine did not lead to pyrrolidine formation, but instead 
favored N-acylation. Likewise, unhindered bases, such as the pyridine in Scheme 1, favored the 
organocascade process. The mechanistic pathway for the formation of pyrrolidine with pyridine 
as a base believed by the Corey group to have taken place is shown in Figure 2.  In the proposed 
mechanism, because pyridine is unhindered, the acryloyl chloride can form an activated N-
acrylylammonium complex similar to 4. This activated electrophile then undergoes a 
Scheme 1. Precedent for aza-Michael aldol-lactonization. 
11 
 
nucleophilic attack by 2 to afford intermediate 5 which then cyclizes by internal cycloaddition to 
give 3a and 3b.  
 
 
 
 
This mechanism also explains why highly hindered bases do not lead to pyrrolidine formation 
because they are sterically unable to form an activated N-acrylylammonium complex. Thus the 
acryloyl chloride undergoes direct N-acylation with 2, while the base serves as a simple Bronsted 
base. 
 
Based upon the precedent of the NCMAL methodology and the work of Corey, the proposed 
project sought to develop a more general, asymmetric aza-Michael aldol-lactonization 
organocascade process which would allow for an efficient synthesis of highly substituted 
pyrrolidines. This organocascade process involves an aza-Michael reaction followed by an 
intermolecular aldol-lactonization to form pyrrolidines bearing fused -lactones.   
Figure 2. Corey precedent proposed mechanism. 
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CHAPTER II 
 
METHODS 
 
A retro-synthesis was developed for the asymmetric aza-Michael aldol-lactonization 
organocascade process, Scheme 2. The synthesis of highly substituted asymmetric pyrrolidines 
bearing fused β-lactones was envisioned to involve the reaction of an α amino ketone as a 
Michael donor with an unsaturated acid chloride as a Michael acceptor.  The Michael acceptors 
consist of different commercially available α, β-unsaturated acid chlorides, such as acryloyl 
chloride. On the other hand, the Michael donors are α-amino ketones substrates derived from 
their parent amino acids which are commercially available and enantomerically pure. 
 
 
 
 
 
In performing the aza-Michael aldol-lactonization, conditions similar to those performed by the 
Romo group would be tested first. 4-pyrrolidinopyridine (4-PPY) would be used as an activator 
of the Michael acceptor and diisopropyl ethyl amine (EtN(i-Pr)2) would be used as a 
stoichiometric Bronsted base. The reaction would be carried out in dichloromethane solvent 
(CH2Cl2) at 23 °C would initially follow the Corey precedent. A tandem aza-Michael aldol-
Scheme 2. Tandem aza-Michael aldol-lactonization to be studied. 
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lactonization reaction is shown in Scheme 3, along with various Michael donors and Michael 
acceptors to be studied. 
 
 
 
 
 
 
The variations of the Michael donors and acceptors to be studied will test the effects of steric 
hindrance, electron withdrawing groups, and electron donating groups on the performance of the 
aza-Michael aldol-lactonization. Based on results of the first attempt of the aza-Michael aldol-
lactonization, subsequent changes will also be made to the reaction condition in order to test their 
effects on the yield of pyrrolidine. Such changes include varying the hindrance of the 
Scheme 3. Tandem aza-Michael aldol-lactonization and various Michael donors and acceptors to 
be studied. 
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nucleophile, varying the type and amount of base added, and varying the reaction temperature.  
The main aim is to start off simple and increase the complexity of the reactions gradually. 
 
Because α-amino ketones are not sold commercially, the route shown in Scheme 4 was 
developed for the synthesis of the required α-amino ketone substrates. The N-terminus of the 
amino acid will be protected to yield 10. This resulting compound is then subjected to a Weinreb 
ketone synthesis in order to yield the α-amino ketone 6. The Weinreb ketone synthesis consists 
of the formation of Weinreb amide 11 by reacting 10 with N, O-dimethylhydroxylamine. The 
final methyl alkylation to form the desired Michael donor 6 is then be performed by subjecting 
11 to an organolithium reagent MeLi.
12
 
 
 
 
 
 
  
Scheme 4. General Michael donor synthesis route. 
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CHAPTER III 
 
RESULTS 
 
 
Synthesis of α-amino ketone substrates 
The first Michael donor α-amino ketone targeted was PMB-N-(L)-alanine amino ketone. The N-
PMB group is one of several groups which could varied to probe electronic effects of this group 
on the aza-Michael aldol lactonizaiton. In the Corey precedent, a N-PMB group was utilized. 
Alanine was studied initially because it only bears a simple methyl group but yet has greater 
steric hindrance than that of glycine, R group = H. Experiments performed previously by a 
graduate student, J.C. Reyes, have confirmed the need for the Michael donor to have a more 
sterically hindered α carbon and the Corey precedent also suggests that steric hindrance can 
improve the desired reaction over simple acylation. Protection of the L-alanine 12 with the PMB 
group was performed by reductive amination as shown in Scheme 5.
13
  
 
 
 
 
Reductive amination involves the conversion of a carbonyl group to an amine via in situ 
formation of an imine. Amine 12 was condensed p-anisaldehyde to generate an imine 
intermediate. Any water produced over the course of the reaction was removed by the addition of 
anhydrous MgSO4. The MgSO4 was then removed by filtration and the imine was reduced to an 
Scheme 5. PMB protection of L-alanine N-terminus. 
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amine by the addition of NaBH4. The reaction proved to be very problematic and the overall 
yield of the reaction was low with a 5 % yield. The small amount of pure product was carried 
onto the Weinreb ketone synthesis. In the formation of the Weinreb ketone, the reactions involve 
two subsequent nucleophilic acyl substitutions, the conversion of the acid into an N, O-
dimethylhydroxylamide, also known as a Weinreb amide, followed by treatment with a Grignard 
reagent or an organolithium reagent. Scheme 6 shows the first step of this ketone synthesis as 
applied to the formation of PMB-N-(L)-alanine amino ketone. 
 
 
 
 
The N-protected amino acid was reacted with N, O-dimethylhydroxylamine hydrochloride in 
order to form the Weinreb amide. EDCI was used as a catalyst and Et3N was used as a base.
14 
Formation of amide 14 was successful however the initial scale of the reaction was ~ 25 mg and 
the overall reaction yield was low. The many problems associated with the synthesis of the 
PMB-N-(L)-alanine amino ketone made progress slow, thus because of time limitations the 
synthesis of this amino ketone was halted.  
 
In order to make up for lost time, two different amino ketones, Boc-N-(L)-phenylalanine amino 
ketone and Ts-N-(L)-alanine amino ketone, were synthesized simultaneously. The synthesis route 
of Ts-N-(L)-alanine amino ketone 17 will be described first. Use of the N-Ts group would enable 
Scheme 6. Weinreb amide formation of 13. 
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us to determine the electronic effect of this group on reaction outcome given it is a strong 
electron withdrawing group. As shown in Scheme 7, addition of the N-Ts group to 12 was 
accomplished with p-toluenesulfonyl chloride to deliver sulfonylamide 15. NaOH was used as 
base and the reaction was carried out in aqueous solvent at 60 °C for 6 hours.
15
 The yield of this 
reaction was 53 % delivering 5.4 g of amide 15 as a white solid. This overall reaction was simple 
and because the product could be collected by crystallization without the need for further 
purification.  
 
 
 
 
 
The Weinreb ketone synthesis was then performed. The formation of the Weinreb amide 16 was 
carried out by a procedure similar to the one used by Aggarwai.
16 
The N-protected amino acid 
was coupled to N, O-dimethylhydroxylamine hydrochloride using dicyclohexylcarbodiimide 
(DCCas carboxylic acid activator and 4-methylmorpholine as base. The reaction was carried out 
in dichloromethane at 0 °C for 3 h and then at 23 
°
C for an additional 14 h. The reaction gave a 
72 % yield of amide 16 (1.71 g) as an off white solid. Due to the acidic NH group, 2 equivalents 
Scheme 7. Synthesis route taken in the formation of Ts-N-(L)-alanine amino ketone 17 
which includes a tosyl protection of the N-terminus followed by a Weinreb ketone 
synthesis. 
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of methyl lithium were used to ensure that it reacted with the N, O-dimethylhydroxylamine of 
16. The reaction was successful and a total of 1.22 g (92 %) of 17 was collected as an off white 
solid.  
 
In addition, Boc-N-(L)-phenylalanine amino ketone 20 was synthesized in through the reaction 
sequence shown in Scheme 8. 
 
 
 
 
 
This ketone was synthesized since the phenylalanine R provided greater sterics which we 
expected would aid β-lactone formation while minimizing N-acylation. Because N-Boc-
phenylalanine 18 is commercially available, it was also decided to test the effects of the Boc 
group on β-lactone formation. Protected amino acid 18 was reacted with N, O-
dimethylhydroxylamine hydrochloride as before but using EDCI as activator and N-
methylmorpholine as base. However when N, O-dimethylhydroxylamine hydrochloride and N-
methylmorpholine were added to the reaction the solution was kept at 0 °C for 15 minutes.
17
 The 
reaction gave a 32 % yield, 1.84 g, of 19 as a yellow oil which directly to the final methyl 
lithium addition while making sure to add 2 equivalents of methyl lithium to ensure full 
Scheme 8. Synthesis route taken in the formation of Boc-N-(L)-phenylalanine 18 via a 
Weinreb ketone synthesis. 
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conversion. The reaction was successful and a total of 1.33 g of 20 (97%) was collected as an off 
white solid.  
 
Studies on the asymmetric aza-Michael aldol-lactonization organocascade process 
With the Boc-N-(L)-phenylalanine amino ketone and Ts-N-(L)-alanine amino ketone substrates 
in hand, these were submitted to the aza-Michael aldol-lactonization. There are many variables 
which could be tested in developing the ideal reaction conditions to favor the aza-Michael aldol-
lactonization organocascade process. The first variable to be tested in these studies was the 
nucleophile used in order to generate the desired α, β- unsaturated acylammonium intermediare. 
The nucleophiles commonly employed in the Romo group for related reactions include 
dimethylaminopyridine, 4-pyrrolidinopyridine (4-PPY) and homobenzotetramisol (( ) HBTM 
and optically pure). All other aspects of the reaction were kept constant. 
 
The results of the aza-Michael aldol-lactonization reaction conditions performed thus far on the 
Boc-N-(L)-phenylalanine amino ketone substrate 20 are illustrated in Table 1. The initial aza-
Michael aldol-lactonization performed using 4-PPY as a nucleophile resulted in no reaction 
(Entry 1). It was realized after initiating reaction that the 4-PPY used in Entry 1 was impure and 
thus the substrate was resubmitted to the same reaction conditions using a new batch of 4-PPY 
(Entry 2).  
 
 
 
 
20 
 
 
 
 
 
Using fresh 4-PPY yielded only a slight difference with a trace amount of 22 being produced 
over the course of the reaction. ( ) HBTM also gave results similar to that of 4-PPY where only 
trace amounts of N-acylation product 21 was produced over the course of the reaction (Entry 3). 
To date, none of the reactions carried out thus far with ketone 20 have yielded the desired 
pyrrolidine product. 
 
Similar reactions were also carried out on the Ts-N-(L)-alanine amino ketone substrate 17 (Table 
2). The first reaction was performed with 17 using 4-PPY as nucleophile (Entry 1) which 
resulted in incomplete conversion and the isolation of an unexpected product. The product did 
not show either the 
1
H NMR peaks in the 5-7 ppm region of its spectra which are characteristic 
Entry Base (equiv.) Nucleophile (equiv.) Temp Results 
1
a EtN(i-Pr)2 (1.1) 4-PPY (1.1) 0 °C to 23 °C no reaction 
2 EtN(i-Pr)2 (1.1) 4-PPY (1.1) 0 °C to 23 °C 
Recovered 20, trace 
amounts 21 
3 EtN(i-Pr)2 (1.1) ( ) HBTM  (1.1) 0 °C to 23 °C 
Recovered 20, trace 
amounts 21 
Table 1. Studies performed on Boc-N-(L)-phenylalanine amino ketone substrate 20. 
 
a
1 not added dropwise. 
21 
 
of alkene protons which would be present in 22, nor the characteristic β-lactone carbonyl peak 
around 1820 cm
-1
 which would be present in 23. After further characterization, it was concluded 
that the product of Entry 1 was likely 22 where chloride ion had reacted to form acylated product 
24.   
 
 
 
 
 
It is possible that use of an older bottle of  4-PPY led to inferior results, yet it is important to 
point out that the product which was isolated from this reaction shows N-acylation did take 
place. The reaction was repeated with fresh 4-PPY (Entry 2) and this second attempt confirmed 
that N-acylation was favored by 4-PPY with respect to the Ts protected alanine substrate. IR 
showed the absence of β-lactone peak around 1820 cm-1 and 1H NMR confirmed that 22 was the 
Entry Base (equiv.) Nucleophile (equiv.) Temp Results 
1
a EtN(i-Pr)2 (1.1) 4-PPY (1.1) 0 °C to 23 °C 
recovered 17 60%, 24 N-
acylation product 29 % 
2 EtN(i-Pr)2 (1.1) 4-PPY (1.1) 0 °C to 23 °C 22 23 % 
3 EtN(i-Pr)2 (1.1) ( ) HBTM  (1.1) 0 °C to 23 °C 23a and 23b
b 
Table 2. Studies performed on Ts-N-(L)-alanine amino ketone substrate 17. 
 
a
1 not added dropwise. 
b
Further purification needed in order to determine yields of each 
individual diastereomers. 
22 
 
major product isolated with the presence of alkene proton peaks at 5.82, 6.41, and 7.01 ppm. On 
the other hand, ( ) HBTM (Entry 3) gave more promising results with the characteristic β-
lactone IR carbonyl peak at 1828 cm
-1
. A first attempt at purification allowed only for the 
isolation of 22. The diastereomers 23a and 23b however, were isolated together. 
1
H NMR 
confirmed the formation of pyrrolidine product by the presence of methyl proton peaks which 
had been shifted up field before 2.00 ppm. The 
1
H and 
13
 C NMR also confirmed the presence of 
both diastereomers in the second isolated product. Further purification and characterization will 
be necessary in order separate the diastereomers and obtain an accurate yield of 23a and 23b. 
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CHAPTER IV 
 
CONCLUSIONS 
 
 
Conclusion 
The development of the asymmetric aza-Michael aldol-lactonization organocascade process is 
still in its infancy as there are many substrates, acid chlorides, and reaction conditions which 
have yet to be studied. However, the results obtained in studies performed thus far have provided 
useful information for future work. The successful production of 23a and 23b involving Michael 
donor Ts-N-(L)-alanine amino ketone substrate 17 when HBTM is used as a nucleophile (Table 
2, Entry 3) has confirmed that highly substituted pyrrolidines can indeed be formed between an 
α-amino ketone and acryloyl chloride via an aza-Michael aldol-lactonization organocascade 
process. However the contrasting results obtained from the changing the nucleophile in the 
reaction to 4-PPY, in which N-acylation was the major product and pyrrolidine was not formed, 
raises questions as to what exactly is the effect the nucleophile on the reaction. Does the steric 
hindrance introduced by the ( ) HBTM nucleophile help drive the reaction to undergo the 
organocascade process rather than N-acylation? If so, then why was there no production of 
pyrrolidine product with the Boc-N-(L)-phenylalanine amino ketone substrate?  Thus, the 
protecting group of the amino ketone substrate may also play an important role in driving the 
reaction toward the aza-Michael aldol-lactonization organocascade process. Further research will 
be necessary in order to determine which nucleophiles and protecting groups possess the ideal 
chemical properties for the desired organocascade process.  
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Future work 
Currently, further purification is being carried out in order to separate the pyrrolidine 
diastereomers produced in the HBTM study and determine a yield for the reaction. Because of 
the positive results obtained with the Ts-N-(L)-alanine amino ketone substrate and HBTM 
nucleophile, further screening will be conducted on this substrate in order to optimize the 
reaction and increase the overall yield of the reaction. Further screening will be conducted on 
amino ketone substrates 17 and 20 using various bases, nucleophiles, and reaction conditions in 
order to test which other conditions can produce the desired pyrrolidine. In addition, acid 
chlorides will also begin to be varied in order to try and increase the substitution of the final  
pyrrolidine products.  
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3. Planned substrates for future studies of aza-Michael aldol-lactonization. 
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Alanine and phenylalanine amino ketone substrates will also be remade with different protecting 
groups in order to test how changing the chemical properties of the protecting groups affect the 
outcome of the aza-Michael aldol-lactonization. Finally, additional α-amino ketone substrates, 
Figure 3, will continue to be synthesized in order to test their efficiency in undergoing the aza-
Michael aldol-lactonization organocascade process.  
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APPENDIX 
 
 
Experimental procedures and characterization data 
All chemicals were purchased from EMD, BioSciences, and Aldrich. Reactions were monitored 
by thin layer chromatography (TLC) on silica Merck 60 F254.  TLCs were carried out in a 
EtOAc:Hexane solvent system. Purification of products was carried out via column 
chromatography and extraction techniques. 
1
H NMR and 
13
C NMR characterization was 
performed on an Inova 300 MHz spectrometer.  Chemical shifts (δ) are expressed in ppm and are 
referenced to deutero-chloroform (δ 7.23 ppm) unless otherwise noted.  Multiplicities are 
represented as follows: s (singlet), d (doublet), t (triplet), q (quartet), dt (doublet of triplets), m 
(multiplet), bs (broad singlet). 
 
 
Tosyl-N-L-alanine (15). To a stirred suspension of L-alanine 12 (5.00 g, 56 mmol)  in 125 mL 
of water at room temperature was added 6.4 g (168 mmol) of NaOH and 12.81 g (67.2 mmol) of 
p-toluene sulfonyl chloride. The mixture was stirred at 60 °C for 6 hours. The solution was then 
cooled to 0 °C and acidified to a pH 1 by addition of concentrated HCl. The solution was put in 
freezer to aid in solidification. The precipitate was collected by filtration and washed with cold 
H2O. The collected solid was air dried to yield 5 as a white solid (1.71 g, 53 %). 
1
H NMR (300 
MHz, CD3OD) δ 7.22 (d, J=7.8 Hz, 2H), 6.84 (d, J=7.8 Hz, 2H), 3.28 (t, 1H), 1.89 (s, 3H), 0.78 
(d, J=7.2 Hz, 3H). 
28 
 
 
 
(R)-N-methoxy-N-methyl-2-(4-methylphenylsulfonamido)propanamide (8). To a solution of 
5 (2.00g mg, 8.22 mmol), N-methylmorpholine (0.99 mL, 9.04 mmol), N,O-
dimethylhydroxylamine.HCl (0.88 g, 9.04 mmol) in anhydrous CH2Cl2 (37.7 mL) was cooled to 
0 °C under nitrogen and treated with N,N-dicyclohexylcarbodiimide (1.86 g, 9.04 mmol) 
portion-wise over 10 minutes. The reaction mixture was stirred at 0 °C for 3 hours followed by a 
further 15 hours at room temperature, then filtered through Celite and concentrated under 
reduced pressure. The residue was then dissolved in CH2Cl2 (50 mL) and washed with saturated 
aqueous sodium bicarbonate solution (2 × 50 mL ), 1 M aqueous HCl solution (2 × 50 mL ), 
brine (1 × 50 mL) and dried (MgSO4). The resulting crude oil was then purified by flash 
chromatography, eluting with 50 % EtOAc/Hexane, to give the desired Weinreb amide as an 
opaque oil after concentration under reduced pressure (1.71 g, 72%).  Rf  (EtOAc/hexanes 3:5) = 
0.35; 
1
H NMR (300 MHz, CDCl3) δ 7.71-7.68 (m, 2 H), 7.27-7.24 (m, 2H), 5.60 (d, J= 9.5 Hz, 
1H), 4.34 (m, 1H) 3.54 (s, 3H), 2.97 (s, 3H), 2.40 (s, 3H), 1.30 (d, J= 7.0 Hz, 3H). 
    
Tert-butyl (1-(methoxy(methyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (19). To a 
solution of Boc-N-L-phenylalanine (1.0 equiv) in dichloromethane (0.24 M) were added HOBt 
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(1.1 equiv) and EDC (1.2 equiv) at 0 °C. The solution was stirred at 0 °C for 15 min and then 
N,O-dimethylhydroxylamine hydrochloride salt (1.15 equiv) and N-methyl morpholine (1.2 
equiv) were added. The reaction mixture was stirred at 25 °C for 14 h. After the solvent was 
removed under vacuum, the resulting residue was partitioned between 1N HCl (aq.) and EtOAc. 
The phases were separated and the organic layer was washed with 1 M  HCl (aq.), followed by 
saturated NaHCO3 and brine, and then dried over MgSO4. After completely removing the 
solvent, the Weinreb amide was purified by flash chromatography. Rf  (EtOAc/hexanes 1:5) = 
0.25;
 1
H NMR (300 MHz, CDCl3) δ 7.30 (t, J = 7.5 Hz, 2H), 7.25 (t, J = 7.5 Hz, 3H), 5.23 (d, 
1H, J = 7.0 Hz), 4.90 (br, 1H), 3.69 (s, 3H), 3.20 (s, 3H), 3.02 (dd, 1H, J = 4.5, 13.5 Hz), 2.81 
(dd, 1H, J = 7.0, 13.0 Hz), 1.40 (s, 9H).  
 
General procedure for amino ketones 17 and 19 
The Weinreb amide (1.00 equiv) was placed in an oven dried round bottom flask equipped with a 
magnetic stir bar and placed under N2 atmosphere. The Weinreb amide was then dissolved in 
anhydrous THF (15 mL) and cooled to -78 °C. While stirring vigorously, MeLi (2 equiv) was 
added dropwise via syringe over 10 minutes. After the addition, the reaction was allowed to stir 
while gradually increasing the temperature to 0 °C. After 20 minutes, the reaction was quenched 
with saturated NH4Cl solution and the mixture was then extracted with EtOAc. The organic layer 
was combined, dried with MgSO4, and concentrated by rotary evaporation. The crude was then 
purified by flash column chromatography (gradient SiO2, EtOAc/hexanes solvent system) to 
afford the α-amino ketone. 
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(R)-4-methyl-N-(3-oxobutan-2-yl)benzenesulfonamide (17) was prepared from 16 (1.30 g, 
4.54 mmol). Flash chromatography (50% EtOAc/Hexanes) afforded 1.01 g of 17 as an off-white 
solid.
  
Rf  (EtOAc/hexanes 3:5) = 0.60; 
1
H NMR (300 MHz, CDCl3) δ 7.72 (d, J= 6.0 Hz, 2 H), 
7.30 (d, J= 12.0 Hz, 2H), 5.51 (d, J= 6.0 Hz, 1H), 3.93 (m, 1H), 2.42 (s, 3H), 2.1 (s, 3H), 1.38 (d, 
J=9.0 Hz, 3H). 
13
C NMR (300 MHz; CDCl3) δ 164.8, 143.6, 136.7, 129.67, 126.9, 57.5, 26.1, 
21.4, 18.7. 
 
 
 
(R)-tert-butyl (3-oxo-1-phenylbutan-2-yl)carbamate (20) was prepared from 19 (1.41 g, 5.59 
mmol). Flash chromatography (30% EtOAc/Hexanes) afforded 1.18 g of 20 as an off-white 
solid. . Rf  (EtOAc/hexanes 1:5) = 0.47;
 1
H NMR (300 MHz, CDCl3) δ 7.34-7.625 (m, 3 H), 7.17 
(d, J=9.0 Hz, 2H), 5.13 (d, J= 6.0 Hz, 1H), 4.54 (q, 1H), 2.42 (dd, 2H), 2.14 (s, 3H), 1.42 (s, 9H).
 
13
C NMR (300 MHz, CDCl3) δ 27.8, 28.2, 37.4, 48.0, 60.6, 126.9, 128.5, 128.5, 129.1, 136.0 
206.8. 
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General procedure for asymmetric aza-Michael aldol-lactonization  
To an oven-dried vial equipped with a stir bar was added the α-amino ketone substrate (50 mg, 1 
.0 equiv). The nucleophile (1.1 equiv) was added to the vial. The vial was capped, sealed with 
Parafilm, put under N2 atmosphere for 2 minutes. The solids were then dissolved in CH2Cl2 
solvent (0.7 mL), followed by the addition of base (1.1 equiv). The solution was then cooled to 0 
°C in an ice bath. 1 (2.0 mL of 0.1 M solution in CH2Cl2, 1.5 equiv) was then added dropwise via 
syringe pump over 2 hours. The reaction was then quenched with water (2.0 mL) and extracted 
with EtOAc (3   2.0 mL). The organic layers were combined, dried with MgSO4, and 
concentrated via rotary evaporation. The crude was then purified by flash column 
chromatography (gradient SiO2, 20  60 % EtOAc/hexanes solvent system). 
 
 
(S)-N-(3-oxobutan-2-yl)-N-tosylacrylamide (22). Prepared from 17 (50 mg, 0.12 mmol) and 4-
PPY nucleophile (32 mg, 0.22 mmol). Flash chromatography afforded 22 as a solid (20 mg, 23 
%). Rf  (EtOAc/hexanes 3:5) = 0.76; 
1
H NMR (300 MHz, CDCl3) δ 7.87 (d, J= 9.0 Hz, 2 H), 
7.39 (d, J= 6.0 Hz, 2H), 7.01 (q, J= 6.0 Hz, 1H), 6.39 (dd, 1H), 5.80 (dd, 1H), 4.71 (q, J= 6.0 Hz, 
1H), 2.47(s, 3H),  2.16 (s, 3H), 1.52 (d, J= 6.0 Hz, 3H). 
13
C NMR (300 MHz; CDCl3) δ 203.1, 
164.9, 145.3, 136.3, 131.8, 130.0, 127.4, 62.4, 25.9, 21.6, 15.03. 
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(1S,4S,5S)-4,5-dimethyl-3-tosyl-6-oxa-3-azabicyclo[3.2.0]heptan-7-one (23a). 
 
Prepared from 
17 (50 mg, 0.12 mmol) and (±) HBTM nucleophile (58 mg, 0.22 mmol). IR: 1828 cm 
-1
 (C=O).
 
1
H NMR (300 MHz, CDCl3) δ 7.73 (d, J= 6.0 Hz, 2 H), 7.36 (d, J= 9.0 Hz, 2H), 4.29 (q, J= 6.0 
Hz, 1H), 3.98 (d, J= 9.0 Hz, 1H), 3.60 (q, J= 6.0 Hz, 3H), 4.71 (q, J= 6.0 Hz, 1H), 2.11 (s, 3H),  
1.63 (s, 3H), 1.47 (d, J= 6.0 Hz, 3H). 
13
C NMR (300 MHz; CDCl3) δ 167.3, 144.3, 129.8, 127.7, 
86.9, 61.3, 59.0, 48.1, 21.5, 18.48, 12.9. 
 
 
 
(1R,4S,5R)-4,5-dimethyl-3-tosyl-6-oxa-3-azabicyclo[3.2.0]heptan-7-one (23b). Prepared from 
17 (50 mg, 0.12 mmol) and (±) HBTM nucleophile (58 mg, 0.22 mmol). IR: 1828 cm 
-1
 (C=O).
 
1
H NMR (300 MHz, CDCl3) δ 7.71 (d, J= 6.0 Hz, 2 H), 7.31 (d, J= 9.0 Hz, 2H), 4.13 (q, J= 6.0 
Hz, 1H), 3.87 (q, J= 9.0 Hz, 1H), 2.99 (d, J= 6.0 Hz, 3H), 4.71 (q, J= 6.0 Hz, 1H), 2.06 (s, 3H),  
1.58 (s, 3H), 1.1.32 (d, J= 6.0 Hz, 3H). 
13
C NMR (300 MHz; CDCl3) δ 167.1, 143.8, 129.6, 
127.0, 85.8, 80.8, 55.2, 45.2, 17.7, 16.01, 12.9. 
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